Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination.
10.1007/s11684-021-0895-9
- Author:
Prathit A KULKARNI
1
;
Vinay PRASAD
2
Author Information
1. Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA. pakulkar@bcm.edu.
2. Department of Epidemiology and Biostatistics, School of Medicine, University of California-San Francisco, San Francisco, CA, 94143, USA.
- Publication Type:Journal Article
- MeSH:
Ad26COVS1;
COVID-19;
Humans;
SARS-CoV-2;
Thrombocytopenia;
Thrombosis/prevention & control*;
Vaccination
- From:
Frontiers of Medicine
2021;15(6):938-941
- CountryChina
- Language:English
